Curanex Pharmaceuticals (CURX) Change in Cash (2024 - 2025)
Curanex Pharmaceuticals' (CURX) quarterly Change in Cash came in at -$857403.0 in Q4 2025, down 798.5% YoY from $122749.1 in Q4 2024, and down 114.99% on a QoQ basis from $5.7 million in Q3 2025.
Curanex Pharmaceuticals (CURX) Change in Cash (2024 - 2025) Analysis & Trends
Curanex Pharmaceuticals (CURX) has 2 years of Change in Cash data on file, last reported at -$857403.0 in Q4 2025.
- Quarterly Change in Cash fell 798.5% year-over-year to -$857403.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.6 million (changed N/A YoY) and the FY2025 annual result came in at $4.8 million, up 6373.32% from the prior year.
- Change in Cash retreated to -$857403.0 in Q4 2025, from $5.7 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $5.7 million in Q3 2025 to a low of -$857403.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Curanex Pharmaceuticals | 6.02 Mn | 1.02 Mn | - | -857,403.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -857,403.00 |
| Sep 30, 2025 | 5.72 Mn |
| Dec 31, 2024 | -95,426.00 |
| Sep 30, 2024 | -129,944.00 |